Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-21-000144

Chief R&D Officer gave up 637 shares (to pay taxes)

  • Chief R&D Officer acquired 2,572 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Scopelianos Angelo Chief R&D Officer 2021-07-19 Grant or award +2,572 10,757 D: show line 1 in the form
Scopelianos Angelo Chief R&D Officer 2021-07-20 Shares withheld for taxes −637 $19.20 $12,230 10,120 D: show line 2 in the form
Loading xslF345X03/wf-form4_162689844445878.xml…